BEAM
Beam Therapeutics Inc
Price:  
24.37 
USD
Volume:  
1,966,396.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BEAM Stock Forecast & Price Target

BEAM Stock Price Forecast

The average stock forecast for Beam Therapeutics Inc (BEAM) in the next 12 months is 52.26 USD. This price target corresponds to an upside of 80.09%. The range of stock forecasts for BEAM is 26.26 - 84.00 USD. Based on the ratings of 23 analysts, the consensus recommendation for BEAM is BUY.
Target Low Average Median High
Price (USD) 26.26 52.26 46.57 84.00
Upside -9.51% 80.09% 60.49% 189.46%

Recommendation Trends

The latest consensus rating for BEAM is "BUY". This is the average recommendation of 23 analysts: 0 strong sell, 0 sell, 3 hold, 11 buy, 9 strong buy. In the previous period, 23 analysts also majorly recommmended "BUY" for BEAM.

BEAM Financial Stock Forecast

Revenue This Year
62.29M
-55.42%
from 139.74M
Revenue Next Year
70.69M
13.49%
from 62.29M
EPS This Year
-4.49
477.29%
from -0.78
EPS Next Year
-4.71
4.91%
from -4.49